MedTrace Logo

Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas

NCT07506161 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2026-06-09

No results posted yet for this study

Summary

Researchers in this study aim to prove the safety and efficacy of radiofrequency ablation in the treatment of a carefully selected low-risk papillary thyroid microcarcinoma patient group.

Conditions

  • Papillary Thyroid Microcarcinoma

Interventions

PROCEDURE

Radiofrequency ablation alone

Ultrasound-guided percutaneous radiofrequency ablation of T1N0M0 papillary thyroid microcarcinomas

Sponsors & Collaborators

  • Ministry of Innovation and Technology, Hungary

    collaborator OTHER_GOV

  • Semmelweis University

    collaborator OTHER

  • Premier G Med Cardio Kft

    lead INDUSTRY

Principal Investigators

  • Pál Á Deák, MD PhD associate professor · Semmelweis University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-09
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07506161 on ClinicalTrials.gov